Having developed a late stage prototype for the bozzini® Hysteroscopy simulator, Inovus were seeking funding to accelerate the product to market readiness in 2018. The company were supported in an application to the EIT Health Headstart programme by the local Academic Health Science Network, the Innovation Agency. Following a successful application to the programme, Inovus were one of 10 companies to be awarded a share of 500,000 Euros. The funding accelerated the final development stages of the bozzini® Hysteroscopy simulator which has been a major success since its launch, now used across four continents for hysteroscopy skills training.